Chikungunya laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
m Changes made per Mahshid's request |
||
| Line 26: | Line 26: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Togaviruses]] | [[Category:Togaviruses]] | ||
[[Category:Tropical disease]] | [[Category:Tropical disease]] | ||
Latest revision as of 17:23, 18 September 2017
|
Chikungunya Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chikungunya laboratory findings On the Web |
|
American Roentgen Ray Society Images of Chikungunya laboratory findings |
|
Risk calculators and risk factors for Chikungunya laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]
Overview
There are no pathognomonic laboratory findings for Chikungunya virus infection. Laboratory abnormalities include mild thrombocytopenia (>100,000/mm3), neutropenia, lymphopenia, and elevated liver function tests. Erythrocyte sedimentation rate and C-reactive protein are usually elevated.[1]
Laboratory Findings
Laboratory abnormalities include the followings:[1]
- Mild thrombocytopenia (>100,000/mm3)
- Leukopenia (including neutropenia and lymphopenia)
- Elevated AST and/or ALT
- Elevated erythrocyte sedimentation rate (ESR)
- Elevated C-reactive protein (CRP)
References
- ↑ 1.0 1.1 Preparedness and response for Chikungunya virus introduction in the Americas. Washington, DC: Pan American Health Organization CDC, Center for Disease Control and Prevention. 2011. ISBN 978-92-75-11632-6.